Stay updated on Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed the older Notice about government funding lapses and operating status (Revision: v3.4.1).SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a funding-status notice about potential data-outdatedness due to a government funding lapse and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedNew UI/text additions include a 'Show glossary' option, a 'Last Update Submitted that Met QC Criteria' label (replacing the previous 'Last Update Submitted that met QC Criteria'), and capitalization tweaks for the No FEAR Act notice, along with a Revision badge showing v3.4.0 instead of v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section expanded to add numerous new sites across the US, Canada, Europe, and other regions, while several locations were removed. A revision tag v3.3.3 is also introduced.SummaryDifference3%

- Check92 days agoChange DetectedThe Publications section now distinguishes between volunteer-provided publications and those automatically filled from PubMed. It also records Revision: v3.3.2.SummaryDifference0.4%

Stay in the know with updates to Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page.